- Home
- MTEN vs ANEB Comparison
MTEN vs ANEB Comparison
Compare MTEN & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTEN | ANEB |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 96.8M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MTEN | ANEB |
|---|---|---|
| Price | $0.59 | $2.21 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 138.0K | 16.6K |
| Earning Date | 10-01-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,735,337.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.63 | N/A |
| 52 Week Low | $0.80 | $0.80 |
| 52 Week High | $26.03 | $3.42 |
Technical Indicators
Market Signals| Indicator | MTEN | ANEB |
|---|---|---|
| Relative Strength Index (RSI) | 14.50 | 42.13 |
| Support Level | $0.80 | $2.26 |
| Resistance Level | $1.26 | $2.30 |
| Average True Range (ATR) | 0.24 | 0.11 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 5.53 | 18.75 |
Price Performance
Historical ComparisonAbout MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.